Predicting survival in urothelial cancer patients after immunotherapy using real-world data

被引：2

作者：

Elumalai, T. ^{[1
]}

Aversa, C. ^{[2
]}

Buijtenhuijs, B. ^{[1
]}

Conroy, R. ^{[1
]}

Croxford, W. ^{[1
]}

Das, A. ^{[3
]}

Doss, G. ^{[2
]}

Enting, D. ^{[4
]}

Kitetere, E. ^{[5
]}

Sanderson, B. ^{[5
]}

Vasudev, N. ^{[6
]}

Mistry, H. ^{[7
]}

Choudhury, A. ^{[7
]}

机构：

[1] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England

[2] Guys & St Thomas NHS Fdn Trust, Dept Clin Oncol, London, England

[3] St Jamess Inst Oncol, Dept Clin Oncol, Leeds, W Yorkshire, England

[4] Guys & St Thomas Hosp NHS Trust, Dept Oncol, London, England

[5] Royal Marsden NHS Fdn Trust, Dept Clin Oncol, London, England

[6] Royal Preston Hosp, Dept Clin Oncol, Rosemere Canc Ctr, Preston, Lancs, England

[7] Univ Manchester, Div Canc Sci, Manchester, Lancs, England

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.837

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

765P

引用

页码：S590 / S590

页数：1

共 50 条

[21] Evaluating the survival benefits of adjuvant immunotherapy in muscle-invasive urothelial carcinoma: A real-world experience.
Zahir, Mazyar
Doshi, Chirag
Escobar, Domenique
Xia, Leilei
Miranda, Gus
Cai, Jie
Schuckman, Anne K.
Djaladat, Hooman
Daneshmand, Siamak
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[22] PREDICTING FAST PROGRESSION OF PORTAL HYPERTENSION USING REAL-WORLD DATA
Svangard, Nils
Kiddle, Steven
Gray, Christen
Khader, Shameer
Greasley, Peter
Ambery, Philip
HEPATOLOGY, 2022, 76 : S1176 - S1177
[23] Editorial: Real-world data and real-world evidence in lung cancer
Gristina, Valerio
Eze, Chukwuka
FRONTIERS IN ONCOLOGY, 2024, 14
[24] Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution
Marta Sotelo
Nerea Muñoz-Unceta
Antonio Matorras
Pablo Jara
Clara Castro
Diego Cacho
Belén Caramelo
Ainara Azueta
Ignacio Durán
Clinical and Translational Oncology, 2024, 26 : 682 - 688
[25] Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution
Sotelo, Marta
Munoz-Unceta, Nerea
Matorras, Antonio
Jara, Pablo
Castro, Clara
Cacho, Diego
Caramelo, Belen
Azueta, Ainara
Duran, Ignacio
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (03): : 682 - 688
[26] Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
Stefan Ravizza
Tony Huschto
Anja Adamov
Lars Böhm
Alexander Büsser
Frederik F. Flöther
Rolf Hinzmann
Helena König
Scott M. McAhren
Daniel H. Robertson
Titus Schleyer
Bernd Schneidinger
Wolfgang Petrich
Nature Medicine, 2019, 25 : 57 - 59
[27] Baseline predictors of survival in lung cancer patients: data from the LALUCA real-world registry
Klemm, T.
Lang-Stoeberl, A.
Fabikan, H.
Rodriguez, V. M.
Weinlinger, C.
Hochmair, M.
Illini, O.
Ay, L.
Funk, G. -C.
Mueser, N.
Kirchbacher, K.
Valipour, A.
WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S541 - S542
[28] Real-world data on survival outcomes and characteristics of lung cancer patients in northern serbia.
Bokan, Darijo
Zaric, Bojan
Kovacevic, Tomi
Stojanovic, Goran
Malbasa, Jelena Djekic
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[29] Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
Ravizza, Stefan
Huschto, Tony
Adamov, Anja
Boehm, Lars
Buesser, Alexander
Floether, Frederik F.
Hinzmann, Rolf
Konig, Helena
McAhren, Scott M.
Robertson, Daniel H.
Schleyer, Titus
Schneidinger, Bernd
Petrich, Wolfgang
NATURE MEDICINE, 2019, 25 (01) : 57 - +
[30] Women patients with small-cell lung cancer using immunotherapy in a real-world cohort achieved long-term survival
He, Yuling
Kong, Lingdong
Ji, Xumeng
Zhuo, Minglei
An, Tongtong
Jia, Bo
Chi, Yujia
Wang, Jingjing
Zhao, Jun
Li, Jianjie
Yang, Xue
Chen, Hanxiao
Zhai, Xiaoyu
Tai, Yidi
Ding, Lu
Wang, Ziping
Wang, Yuyan
THORACIC CANCER, 2024, 15 (23) : 1727 - 1738

← 1 2 3 4 5 →